NCT06324942View on ClinicalTrials.gov

Analgesic Efficacy of Surgeon-administered Transversus Abdominis Plane Blocks for Caesarean Section.

NARecruitingINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

February 19, 2025

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions
Cesarean Section ComplicationsPain, Postoperative
Interventions
OTHER

Surgeon-administered Transversus Abdominis Plane Block 0.25% bupivicaine 0.25 mL/kg

Surgeon-administered Transversus Abdominis Plane Block

Trial Locations (1)

T2N 2T9

RECRUITING

University of Calgary, Calgary

All Listed Sponsors
lead

University of Calgary

OTHER